David Jin - May 11, 2022 Form 3 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Signature
/s/ David Jin
Stock symbol
ATXI
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
3
Date filed
5/25/2022, 04:05 PM
Next filing
Aug 25, 2022

No securities are beneficially owned.

Remarks:

Mr. Jin serves as Avenue Therapeutics, Inc.'s Interim Principal Executive Officer, Interim Principal Financial Officer, and Chief Operating Officer. Exhibit List Exhibit 24: Power of Attorney